The effect of dihydroergotamine on growth hormone--induced lipolysis in dogs.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001966:Bromine / Q000494:pharmacology; D002417:Cattle; D004285:Dogs; D004336:Drug Antagonism; D004878:Ergotamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D013006:Growth Hormone / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D007016:Hypophysectomy; D007700:Kinetics; D008053:Lipid Mobilization / Q000187:drug effects*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D010179:Pancreas / Q000502:physiology; D010180:Pancreatectomy; D010646:Phentolamine / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology; D011691:Puromycin / Q000494:pharmacology; D013972:Thyrotropin / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D011691:Puromycin; D008238:Lysergic Acid Diethylamide; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D004878:Ergotamine; D001966:Bromine; D010646:Phentolamine